The Antibody Two-Step Solution.
Ontology highlight
ABSTRACT:
SUBMITTER: Browning M
PROVIDER: S-EPMC4706045 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
Publications
Problems with antibody quality have been described in numerous recent publications. In the present commentary it is argued that these quality problems are due primarily to issues of antibody variability and antibody validation. Further it is argued that the problem of antibody variability must be solved before validation can be useful. A two-step solution to the antibody problem is thus proposed. ...[more]
Similar Datasets
Project description:The COVID-19 pandemic revealed an urgent need for rapid profiling of neutralizing antibody responses and development of antibody therapeutics. The current Food and Drug Administration-approved serological tests do not measure antibody-mediated viral neutralization, and there is a need for standardized quantitative neutralization assays. We report a high-throughput two-step profiling approach for identifying neutralizing convalescent plasma. Screening and downselection for serum antibody binding to the receptor-binding domain are followed by quantitative neutralization testing using a chimeric vesicular stomatitis virus expressing spike protein of SARS-CoV-2 in a real-time cell analysis assay. This approach enables a predictive screening process for identifying plasma units that neutralize SARS-CoV-2. To calibrate antibody neutralizing activity in serum from convalescent plasma donors, we introduce a neutralizing antibody standard reagent composed of two human antibodies that neutralize SARS-CoV strains, including SARS-CoV-2 variants of concern. Our results provide a framework for establishing a standardized assessment of antibody-based interventions against COVID-19.
| S-EPMC8653399 | biostudies-literature
Project description:Advances in antibody discovery technologies, especially with the availability of humanized mice and phage/yeast library approaches, enable the generation of a large diversity of antibodies against nearly any target of interest. As a result, there is an increasing demand for the production of larger numbers of purified antibodies at quantities (10s-100s of milligrams) sufficient for functional screening assays, drug-ability/develop-ability studies and immunogenicity assessments. To accommodate this need, new methods are required that bridge miniature high throughput/plate-based purification and conventional, one at a time, two-step purification at much larger scales. Thus, we developed a semi-automated, mid-scale (i.e., 1-75 mg) purification process that uses a combination of parallel affinity capture and automated sequential polishing to provide substantially improved throughput while delivering high purity. We optimized the affinity capture step to perform 24 monoclonal antibody purifications in parallel using a Protein Maker for 20-200 mL culture media. The eluant is transferred directly to an AKTA pure system equipped with an autosampler for sequential preparative size exclusion chromatography to remove aggregates and undesirable impurities, as well as exchange the antibody into a buffer suitable for most uses, including cell-based assays. This two-step purification procedure, together with plate-based protein analytical methods, can purify 24-48 monoclonal antibodies in <20 hours and generate up to 80 mg per sample. A stringent clean-in-place protocol for both systems and column maintenance was designed and established to minimize endotoxin contamination. This process has proven to be very reliable and robust, enabling the production of thousands of antibodies of sufficient quality and quantity that are suitable for cell-based assays, biochemical/biophysical characterization, and in vivo animal models.
| S-EPMC8604386 | biostudies-literature
Project description:Changes of molecular spin are ubiquitous in chemistry and biology. Among spin flip processes, one of the fastest is intersystem crossing (ISC) in transition metal complexes. Here, we investigate the spin relaxation dynamics and emission spectrum of [Re(CO)3(im)(phen)]+ (im = imidazole, phen = phenanthroline) using extensive full-dimensional excited-state dynamics simulations in explicit aqueous solution. Contrary to what has been observed in other transition metal complexes, the transition from the singlet to triplet states occurs via a two-step process, with clearly separable electronic and nuclear-driven components with two different time scales. The initially excited electronic wave function is a "molecular spin-orbit wave packet" that evolves almost instantaneously, with an 8 fs time constant, into an approximate 25?:?75 singlet-to-triplet equilibrium. Surprisingly, this ISC process is an order of magnitude faster than it was previously documented for this and other rhenium(i) carbonyl diimine complexes from emission spectra. Simulations including explicit laser field interactions evidence that few-cycle UV laser pulses are required to follow the creation and evolution of such molecular spin-orbit wave packets. The analysis of the dynamics also reveals a retarded ISC component, with a time constant of 420 fs, which can be explained invoking intramolecular vibrational energy redistribution. The emission spectrum is shown to be characterized by ISC convoluted with internal conversion and vibrational relaxation. These results provide fundamental understanding of ultrafast intersystem crossing in transition metal complexes.
| S-EPMC6988600 | biostudies-literature
Project description:Perovskite semiconductors hold a unique promise in developing multijunction solar cells with high-efficiency and low-cost. Besides design constraints to reduce optical and electrical losses, integrating several very different perovskite absorber layers in a multijunction cell imposes a great processing challenge. Here, we report a versatile two-step solution process for high-quality 1.73 eV wide-, 1.57 eV mid-, and 1.23 eV narrow-bandgap perovskite films. Based on the development of robust and low-resistivity interconnecting layers, we achieve power conversion efficiencies of above 19% for monolithic all-perovskite tandem solar cells with limited loss of potential energy and fill factor. In a combination of 1.73 eV, 1.57 eV, and 1.23 eV perovskite sub-cells, we further demonstrate a power conversion efficiency of 16.8% for monolithic all-perovskite triple-junction solar cells.
| S-EPMC7567894 | biostudies-literature
Project description:The two-step nucleation model for crystal nuclei formation explains several experimental and theoretical results better than the classical nucleation theory. We report here direct visualization of the two-step nucleation model for organic molecular crystallization. Evaporative crystallization from a solution of a dibenzoylmethane boron complex that displays mechanofluorochromism, a fluorescence color change induced by mechanical perturbation, was probed by fluorescence change. The dependence of fluorescence change on dispersion concentration of the complex in a polymer matrix was also investigated. We detected transitional emission from the amorphous cluster state prior to crystallization. This is the first demonstration of the two-step nucleation model based on fluorescence color changes.
| S-EPMC4782171 | biostudies-literature
Project description:Pb-based hybrid perovskite solar cells, despite their advantages, face challenges in commercialization. In recent years, Bi-based chalcohalides are being considered as potential alternative candidates, however, their current device efficiency remains unsatisfactory. Herein, a two-step solution method is developed and applied to the fabrication of BiSI films. The method consists of the formation of Bi2S3 (step I) and its conversion to BiSI (step II). The Bi2S3 was fabricated by a thiol-amine solution process and the BiSI conversion was achieved by chemical reaction between the as-formed Bi2S3 and BiI3. It was found that the formation of BiSI was highly dependent on the Bi:S molar ratio of the Bi2O3-thiourea solution and the number of times of step I. The as-fabricated BiSI film had an optical band gap of 1.61 eV and exhibited nanorod morphology. In addition, the electronic structure is explored and discussed for solar cells applications.
| S-EPMC6956077 | biostudies-literature
Project description:Investigation of domestication footprints in three major Solanaceae species
| PRJEB26324 | ENA
Project description:PurposeMany cancer treatments suffer from dose-limiting toxicities to vital organs due to poor therapeutic indices. To overcome these challenges we developed a novel multimerization platform that rapidly removes tumor-targeting proteins from the blood to substantially improve therapeutic index.Experimental designThe platform was designed as a fusion of a self-assembling and disassembling (SADA) domain to a tandem single-chain bispecific antibody (BsAb, anti-ganglioside GD2 × anti-DOTA). SADA-BsAbs were assessed with multiple in vivo tumor models using two-step pretargeted radioimmunotherapy (PRIT) to evaluate tumor uptake, dosimetry, and antitumor responses.ResultsSADA-BsAbs self-assembled into stable tetramers (220 kDa), but could also disassemble into dimers or monomers (55 kDa) that rapidly cleared via renal filtration and substantially reduced immunogenicity in mice. When used with rapidly clearing DOTA-caged PET isotopes, SADA-BsAbs demonstrated accurate tumor localization, dosimetry, and improved imaging contrast by PET/CT. When combined with therapeutic isotopes, two-step SADA-PRIT safely delivered massive doses of alpha-emitting (225Ac, 1.48 MBq/kg) or beta-emitting (177Lu, 6,660 MBq/kg) S-2-(4-aminobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid (DOTA) payloads to tumors, ablating them without any short-term or long-term toxicities to the bone marrow, kidneys, or liver.ConclusionsThe SADA-BsAb platform safely delivered large doses of radioisotopes to tumors and demonstrated no toxicities to the bone marrow, kidneys, or liver. Because of its modularity, SADA-BsAbs can be easily adapted to most tumor antigens, tumor types, or drug delivery approaches to improve therapeutic index and maximize the delivered dose.See related commentary by Capala and Kunos, p. 377.
| S-EPMC7855367 | biostudies-literature
Project description:Biparatopic fragment antibodies can overcome deficiencies in avidity of conventional antibody fragments. Here, we describe a technology for generating biparatopic antibodies through two-step targeting using a pair of polypeptides, SpyTag and SpyCatcher, that spontaneously react to form a covalent bond between antibody fragments. In this method, two antibody fragments, each targeting different epitopes of the antigen, are fused to SpyTag and to SpyCatcher. When the two polypeptides are serially added to the antigen, their proximity on the antigen results in covalent bond formation and generation of a biparatopic antibody. We validated the system with purified recombinant antigen. Results in antigen-overexpressing cells were promising although further optimization will be required. Because this strategy results in high-affinity targeting with a bipartite molecule that has considerably lower molecular weight than an antibody, this technology is potentially useful for diverse applications.
| S-EPMC6976922 | biostudies-literature
Project description:BackgroundKidney transplantation is the preferred treatment option for patients with end-stage renal disease. To maximize patient and graft survival, the allocation of donor organs to potential recipients requires careful consideration.ObjectiveThis study aimed to develop an innovative technological solution to enable better prediction of kidney transplant survival for each potential donor-recipient pair.MethodsWe used deidentified data on past organ donors, recipients, and transplant outcomes in the United States from the Scientific Registry of Transplant Recipients. To predict transplant outcomes for potential donor-recipient pairs, we used several survival analysis models, including regression analysis (Cox proportional hazards), random survival forests, and several artificial neural networks (DeepSurv, DeepHit, and recurrent neural network [RNN]). We evaluated the performance of each model in terms of its ability to predict the probability of graft survival after kidney transplantation from deceased donors. Three metrics were used: the C-index, integrated Brier score, and integrated calibration index, along with calibration plots.ResultsOn the basis of the C-index metrics, the neural network-based models (DeepSurv, DeepHit, and RNN) had better discriminative ability than the Cox model and random survival forest model (0.650, 0.661, and 0.659 vs 0.646 and 0.644, respectively). The proposed RNN model offered a compromise between the good discriminative ability and calibration and was implemented in a technological solution of technology readiness level 4.ConclusionsOur technological solution based on the RNN model can effectively predict kidney transplant survival and provide support for medical professionals and candidate recipients in determining the most optimal donor-recipient pair.
| S-EPMC9240927 | biostudies-literature